Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Psilocybine
Therapeutic Area : Psychiatry/Psychology
Study Phase : Undisclosed
Sponsor : HAVN Life Sciences
Deal Size : Undisclosed
Deal Type : Agreement
HAVN Life Announces Supply and Distribution MOU with Mycrodose Therapeutics
Details : HAVN Life will work with its partners to export their naturally derived psilocybin to Mycrodose Therapeutics, where it will be used in the development of advanced drug delivery (ADD) systems to treat mental health and cognitive degenerative diseases.
Product Name : Undisclosed
Product Type : Controlled Substance
Upfront Cash : Undisclosed
September 23, 2021
Lead Product(s) : Psilocybine
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Undisclosed
Sponsor : HAVN Life Sciences
Deal Size : Undisclosed
Deal Type : Agreement